Non-Billable / Non-Specific Code
ICD-10-CM Z19 is the diagnosis code for Hormone sensitivity malignancy status. This code falls under the section "Hormone sensitivity malignancy status" within Chapter 21 — Factors influencing health status and contact with health services (Z00-Z99). It is a non-billable/non-specific ICD-10-CM code that should not be used for reimbursement. A more specific sub-code is required for billing. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
Always refer to the official ICD-10-CM Tabular List for complete coding guidelines. Ensure documentation supports the specificity of the code selected. When in doubt, consult a certified medical coder or the latest CMS guidelines.
Understanding where Z19 sits in the ICD-10-CM classification helps ensure proper coding:
No, Z19 is a non-billable/non-specific code. You should use a more specific sub-code for billing and reimbursement.
Z19 is the ICD-10-CM diagnosis code for "Hormone sensitivity malignancy status". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
Z19 is located in Section Z19 — "Hormone sensitivity malignancy status" within Chapter 21 of the ICD-10-CM Tabular List.
Z19 has 2 sub-code(s) that provide more specific detail: Z19.1, Z19.2.
Use Z19 when the patients documented diagnosis matches "Hormone sensitivity malignancy status" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Hormone sensitivity malignancy status is Z19.
No, Z19 is non-billable. Use a more specific sub-code for primary diagnosis billing.
Z19 is in Chapter 21 of the ICD-10-CM Tabular List.
Yes, Z19 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.